ENTRY       D03896                      Drug
NAME        Dornase alfa (USAN/INN);
            Dornase alfa (genetical recombination) (JAN);
            Pulmozyme (TN)
PRODUCT     PULMOZYME (Genentech)
FORMULA     C1321H1995N339O396S9
EXACT_MASS  29231.3879
MOL_WEIGHT  29249.5937
REMARK      Therapeutic category: 2290
            ATC code: R05CB13
            Product: D03896<JP/US>
EFFICACY    Mucolytic
  DISEASE   Cystic fibrosis [DS:H00218]
COMMENT     Recombinant human DNase
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             R RESPIRATORY SYSTEM
              R05 COUGH AND COLD PREPARATIONS
               R05C EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS
                R05CB Mucolytics
                 R05CB13 Dornase alfa (desoxyribonuclease)
                  D03896  Dornase alfa (USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Respiratory Tract/Pulmonary Agents
              Cystic Fibrosis Agents
               Cystic Fibrosis Agents, Other
                Dornase Alfa
                 D03896  Dornase alfa (USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              22  Respiratory organ agents
               229  Miscellaneous
                2290  Miscellaneous
                 D03896  Dornase alfa (USAN/INN); Dornase alfa (genetical recombination) (JAN)
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D03896
DBLINKS     CAS: 143831-71-4
            PubChem: 17397980
///
